Technique developed in MCDB's Pace Lab used to identify bacteria in Cystic Fibrosis Patients
Molecular technology developed by a University of Colorado at Boulder professor to probe extreme life forms in undersea hydrothermal vents has been used to identify unexpected bacteria strains in the lung fluid of Denver children suffering from cystic fibrosis, findings that may lead to more effective therapies.
News taken from University of Colorado web page.
For the whole story please visit: